LINAC-based stereotactic radiosurgery (SRS) has gained popularity in treating intracranial tumors. This study aims to compare the dosimetric outcomes of different SRS methods for typical brain tumors of various sizes, as dictated by beam energy, MLC leaf width, and prescribed isodose level (IDL). Hypothetical target lesions of 4 different sizes were contoured on brain MRI images of an index patient. The PTV were constructed to be within 4 respective categories (<0.5, 0.5-1.0, 1.0-4.0, 4.0-10.0 cc), in inverse proportion with prescription dose range of 16-22.5 Gy. For each lesion, SRS plans were analyzed independently between (1) two photon beam energies with different dose rates (6X-FFF with 1400 MU/min vs. 10X-FFF with 2400 MU/min), (2) two MLC leaf widths (0.5 cm vs. 0.25 cm), and (3) two different prescribed isodose lines (90% IDL vs. 80% IDL). The degree of normal tissue sparing was evaluated with the amount of brain volume receiving >12 Gy (V12) and the dose Gradient Index (GI) - defined as the ratio between volume receiving >50% of prescribed dose (V50%) and PTV volume. Tumor dose inhomogeneity was analyzed with respect to the maximum dose (Dmax) deposited, while conformity was assessed via Conformity Index (CI) - defined as the ratio between V100% and PTV volume. Treatment beam-on time was also compared. All 3 independent variables (beam energy, MLC leaf width, and prescribed IDL) were held constant except the one being analyzed, with mean relative differences of the dosimetric outcomes determined for all 4 lesions of respective volumes. The 4 PTV volumes contoured were: 0.35, 0.68, 1.76 and 5.60 cc, respectively. Dmax was affected only by the prescribed IDL, while the tumor CI did not exhibit any significant difference for all 3 variables analyzed. Compared to 10X-FFF, the 6X-FFF plans have lower GI by 11.51%±5.87%, lower V12 by 11.38%±6.98%, and longer beam-on time by 96.41%±4.44%. Compared to 0.25cm MLC leaf-width, the 0.5cm plans have higher GI by 22.12%±8.64%, higher V12 by 22.20%±11.12%, and shorter beam-on time by 2.63%±1.07%. Compared to 80%IDL, the 90%IDL plans have higher GI by 25.73%±9.09%, higher V12 by 25.27%±10.78%, lower Dmax by 11.02%±0.19%, and shorter beam-on time by 12.80%±0.78%. This study showed that (1) lower beam energy plans may provide better brain sparing but incur much longer beam-on time, (2) thinner MLC leaf width may provide better brain sparing at the expense of slightly longer treatment time, and (3) prescribing dose at lower IDL may provide better brain sparing but result in higher tumor dose inhomogeneity and longer beam-on time. It may thus provide useful information for LINAC-based SRS practitioners to better formulate customized treatment strategy based on how beam energy, MLC leaf width and prescribed IDL may each affect tumor dose coverage, normal brain tissue sparing or treatment duration.
Read full abstract